| Product Code: ETC9474533 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Onco-hematology Molecular Testing Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Onco-hematology Molecular Testing Market - Industry Life Cycle |
3.4 Sri Lanka Onco-hematology Molecular Testing Market - Porter's Five Forces |
3.5 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Type, 2021 & 2031F |
3.6 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Biomarker, 2021 & 2031F |
3.8 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Sri Lanka Onco-hematology Molecular Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and hematological disorders in Sri Lanka |
4.2.2 Growing awareness about the benefits of molecular testing in Oncology and Hematology |
4.2.3 Technological advancements in molecular testing leading to more accurate and efficient results |
4.3 Market Restraints |
4.3.1 Limited access to advanced molecular testing technologies in certain regions of Sri Lanka |
4.3.2 High costs associated with molecular testing procedures |
4.3.3 Lack of skilled professionals in onco-hematology molecular testing |
5 Sri Lanka Onco-hematology Molecular Testing Market Trends |
6 Sri Lanka Onco-hematology Molecular Testing Market, By Types |
6.1 Sri Lanka Onco-hematology Molecular Testing Market, By Blood Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Blood Cancer Type, 2021- 2031F |
6.1.3 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021- 2031F |
6.1.4 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Myeloproliferative Neoplasms, 2021- 2031F |
6.1.5 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Myeloid Leukemia, 2021- 2031F |
6.1.6 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F |
6.2 Sri Lanka Onco-hematology Molecular Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By qPCR, 2021- 2031F |
6.2.3 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By dPCR, 2021- 2031F |
6.2.4 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.5 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sri Lanka Onco-hematology Molecular Testing Market, By Blood Cancer Biomarker |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By BCR-ABL1 Mbcr, 2021- 2031F |
6.3.3 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By JAK2, 2021- 2031F |
6.3.4 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By CALR, 2021- 2031F |
6.3.5 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By MPL, 2021- 2031F |
6.3.6 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By PML-RARA, 2021- 2031F |
6.3.7 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By NPM1, 2021- 2031F |
6.3.8 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.3.9 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.4 Sri Lanka Onco-hematology Molecular Testing Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By National Reference Lab / Specialty Lab, 2021- 2031F |
6.4.3 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By University Hospital / Oncology Center, 2021- 2031F |
6.4.4 Sri Lanka Onco-hematology Molecular Testing Market Revenues & Volume, By Community Hospital / IDN (Regional/National), 2021- 2031F |
7 Sri Lanka Onco-hematology Molecular Testing Market Import-Export Trade Statistics |
7.1 Sri Lanka Onco-hematology Molecular Testing Market Export to Major Countries |
7.2 Sri Lanka Onco-hematology Molecular Testing Market Imports from Major Countries |
8 Sri Lanka Onco-hematology Molecular Testing Market Key Performance Indicators |
8.1 Percentage increase in the adoption rate of molecular testing in onco-hematology |
8.2 Number of research studies and clinical trials incorporating molecular testing in Sri Lanka |
8.3 Improvement in turnaround time for molecular testing results |
9 Sri Lanka Onco-hematology Molecular Testing Market - Opportunity Assessment |
9.1 Sri Lanka Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Type, 2021 & 2031F |
9.2 Sri Lanka Onco-hematology Molecular Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Sri Lanka Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Biomarker, 2021 & 2031F |
9.4 Sri Lanka Onco-hematology Molecular Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Sri Lanka Onco-hematology Molecular Testing Market - Competitive Landscape |
10.1 Sri Lanka Onco-hematology Molecular Testing Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Onco-hematology Molecular Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here